Data from the National Cancer Database, which is heavily dependent on institutional reporting, could be misleading about the burden of sarcomas in the United States. READ MORE
Pediatric patients with head and neck sarcoma can be treated with proton beam therapy and experience similar outcomes with less impact on quality of life compared with standard photon radiation.
A recent study demonstrated meaningful clinical activity with limited toxicity in patients with soft-tissue and bone sarcoma after treatment with an immuno-agent.
A recent study compared the safety and efficacy of multiple chemotherapy agents in treating advanced liposarcoma.
While the overall risk of secondary cancers after Kaposi sarcoma has declined in people with HIV/AIDS, clinicians should be aware that certain cancers are becoming increasingly common in the highly active antiretroviral therapy era compared with the pre-HAART era.